NEA Management Company as of June 30, 2018
Portfolio Holdings for NEA Management Company
NEA Management Company holds 43 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 21.7 | $463M | 10M | 44.47 | |
| Adaptimmune Therapeutics (ADAP) | 7.4 | $158M | 13M | 11.87 | |
| Rhythm Pharmaceuticals (RYTM) | 7.2 | $154M | 4.9M | 31.26 | |
| Glycomimetics (GLYC) | 6.9 | $147M | 9.1M | 16.13 | |
| Mersana Therapeutics (MRSN) | 6.8 | $146M | 8.1M | 17.86 | |
| Senseonics Hldgs (SENS) | 6.0 | $127M | 31M | 4.11 | |
| Crispr Therapeutics (CRSP) | 5.8 | $123M | 2.1M | 58.76 | |
| Epizyme | 4.1 | $88M | 6.5M | 13.55 | |
| Obseva Sa | 3.2 | $69M | 4.6M | 15.14 | |
| Ardelyx (ARDX) | 2.7 | $57M | 15M | 3.70 | |
| Ra Pharmaceuticals | 2.6 | $55M | 5.5M | 9.95 | |
| Surface Oncology | 2.5 | $54M | 3.3M | 16.31 | |
| Achaogen | 2.1 | $45M | 5.2M | 8.66 | |
| Synlogic | 1.9 | $42M | 4.2M | 9.83 | |
| AVEO Pharmaceuticals | 1.9 | $40M | 18M | 2.25 | |
| Dermira | 1.5 | $32M | 3.5M | 9.20 | |
| Lexicon Pharmaceuticals (LXRX) | 1.3 | $29M | 2.4M | 12.00 | |
| Clementia | 1.3 | $28M | 2.1M | 13.16 | |
| Aurinia Pharmaceuticals (AUPH) | 1.3 | $27M | 4.8M | 5.63 | |
| Strongbridge Bioph shs usd | 1.2 | $25M | 4.1M | 6.00 | |
| Mei Pharma | 1.1 | $23M | 5.7M | 3.94 | |
| Genocea Biosciences | 1.0 | $21M | 25M | 0.85 | |
| Cti Biopharma | 0.9 | $19M | 3.8M | 4.98 | |
| Verona Pharma Plc ads (VRNA) | 0.8 | $17M | 1.2M | 13.66 | |
| Proteostasis Therapeutics In | 0.7 | $16M | 5.6M | 2.79 | |
| Endologix | 0.7 | $14M | 2.5M | 5.66 | |
| ArQule | 0.7 | $14M | 2.5M | 5.53 | |
| Nightstar Therapeutics | 0.5 | $11M | 714k | 16.00 | |
| Champions Oncology (CSBR) | 0.5 | $9.9M | 1.6M | 6.34 | |
| Tracon Pharmaceuticals | 0.4 | $9.4M | 3.5M | 2.70 | |
| Dasan Zhone Solutions | 0.4 | $9.3M | 956k | 9.76 | |
| Rigel Pharmaceuticals (RIGL) | 0.4 | $9.2M | 3.2M | 2.83 | |
| Affimed Therapeutics B V | 0.4 | $8.5M | 5.1M | 1.65 | |
| Trillium Therapeutics, Inc. Cmn | 0.3 | $7.5M | 1.3M | 6.00 | |
| Mongodb Inc. Class A (MDB) | 0.3 | $7.4M | 150k | 49.63 | |
| Regulus Therapeutics | 0.3 | $7.3M | 11M | 0.66 | |
| Arsanis | 0.3 | $7.3M | 2.0M | 3.63 | |
| Erytech Pharma Sa | 0.3 | $7.0M | 625k | 11.17 | |
| Trevena | 0.3 | $5.5M | 3.8M | 1.44 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $2.8M | 1.3M | 2.12 | |
| Tintri Inc. equity | 0.1 | $1.3M | 5.3M | 0.25 | |
| Akari Therapeutics | 0.0 | $882k | 452k | 1.95 | |
| Aytu Bioscience | 0.0 | $12k | 45k | 0.27 |
